Actemra (Tocilizumab) Utilization Among Pregnant Women

Basic Details
Date Posted
Monday, July 17, 2017
Status
Complete
Medical Product
Actemra
tocilizumab
Health Outcome(s)
juvenile rheumatoid arthritis
rheumatoid arthritis
Description

This report contains estimates of tocilizumab use that occurred during a pregnancy resulting in a liveborn delivery, or within 90 days prior to the estimated start of pregnancy. This query request was distributed to 16 Data Partners on February 9, 2017, and requested data that spanned from the time period of January 1, 2010 to September 30, 2015.

Additional Details
FDA Center
CDER
Time Period
2010 - 2015
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
All females 15 to 54 years of age with a live birth between January 2010 - December 2015